Cooley Advised Bain Capital as Lead Investor in OMass Therapeutics' Oversubscribed $310 Million Series C Financing
October 28, 2026
October 28, 2026
PALO ALTO, California, Oct. 28 -- Cooley, a law firm, issued the following news release:
* * *
Cooley Advised Bain Capital as Lead Investor in OMass Therapeutics' Oversubscribed $310 Million Series C Financing
October 27, 2026
Cooley advised Bain Capital Life Sciences as lead investor alongside Forbion and Novo Holdings on the oversubscribed $310 million Series C financing round of OMass Therapeutics, a biotechnology company developing sma . . .
* * *
Cooley Advised Bain Capital as Lead Investor in OMass Therapeutics' Oversubscribed $310 Million Series C Financing
October 27, 2026
Cooley advised Bain Capital Life Sciences as lead investor alongside Forbion and Novo Holdings on the oversubscribed $310 million Series C financing round of OMass Therapeutics, a biotechnology company developing sma . . .